HBK Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

HBK Investments’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-221,225	Closed	-$21M	–	535
2019 Q4	$21M	Buy	221,225 +39,141	+21%	+$3.39M	0.2%	52
2019 Q3	$13.9M	Buy	182,084 +91,684	+101%	+$7.62M	0.18%	74
2019 Q2	$7.93M	Buy	+90,400	New	+$7.71M	0.07%	137
2019 Q1	–	Sell	-44,933	Closed	-$3.22M	–	1383
2018 Q4	$3.22M	Buy	+44,933	New	+$3.62M	0.03%	378

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

HBK Investments's XBI Position: Q1 2020 in Review

HBK Investments sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2020, closing a stake of 221,225 shares — an estimated $21M sold.

HBK Investments first reported a position in XBI in Q4 2018 and held it in 4 quarters. The position peaked at $21M in Q4 2019. 458 funds tracked by Wall St. Rank hold XBI as of Q1 2020.

HBK Investments reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2020 after selling out during the quarter.
HBK Investments sold 221,225 State Street SPDR S&P Biotech ETF shares in Q1 2020, an estimated $21M.
HBK Investments first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and held it in 4 quarters.
HBK Investments's State Street SPDR S&P Biotech ETF position peaked at $21M in Q4 2019.
458 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2020.

Based on HBK Investments's 13F filing for Q1 2020, filed 15 May 2020.